Namita Thapar said that she has lived in the US for eight years and found that many Indians living there were not very optimistic about the state of India.
Emcure Pharma, led by Shark Tank India's Namita Thapar, has received SEBI approval for an IPO, expected within two months. The IPO includes ₹800 crore in new equity and an offer for sale of 1.36 crore shares.
/startuppedia/media/media_files/2025/04/10/yymk94uU1WcqzdrQhbvx.jpeg)
/startuppedia/media/media_files/Cb6kCns2rXBg4a9UkXDN.png)